Oncolytics Biotech
ONCY
#9071
Rank
S$0.15 B
Marketcap
S$1.43
Share price
6.60%
Change (1 day)
50.94%
Change (1 year)

Oncolytics Biotech (ONCY) - Total debt

Total debt on the balance sheet as of September 2025 : S$0.75 Million

According to Oncolytics Biotech 's latest financial reports the company's total debt is S$0.75 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Oncolytics Biotech - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$1 M139.28%
2023-12-31S$0.42 M14.3%
2022-12-31S$0.36 M-46.96%
2021-12-31S$0.69 M66.56%
2020-12-31S$0.41 M-20.18%
2019-12-31S$0.52 M
2018-12-31N/A
2006-12-31S$0.19 M-7.91%
2005-12-31S$0.21 M5.29%
2004-12-31S$0.2 M3.7%
2003-12-31S$0.19 M19.22%
2002-12-31S$0.16 M-5.46%
2001-12-31S$0.17 M0.45%
2000-12-31S$0.17 M0.21%
1999-12-31S$0.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eli Lilly
LLY
S$53.83 B 7,087,206.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$59.71 B 7,860,251.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
S$63.61 M 8,274.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
S$2.13 M 181.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$21.65 B 2,850,296.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
S$48.99 M 6,349.83%๐Ÿ‡บ๐Ÿ‡ธ USA